Javier Ochoa-Repáraz

Has grant

Assistant Professor

Boise State University

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Javier Ochoa-Repáraz is an Assistant Professor at Boise State University in the United States. His research primarily focuses on the interplay between gut microbiota and autoimmune diseases, particularly in relation to multiple sclerosis, as evidenced by his recent publications. He has also explored the effects of genetically engineered Lactococcus lactis and farnesol on central nervous system conditions and microbiome dynamics.

Recent Grants

Grant: Close

Targeting the GABA-modulator microbiota against the progression of CNS inflammatory demyelination

Open Date: 2019-07-15

Close Date: 2022-06-30

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Brett Pickett

Assistant Professor

Brigham Young University

UNITED STATES

View details

Anirban Chakraborty

Assistant Professor

University of Idaho

UNITED STATES

View details

Andrea Castillo

Professor

Eastern Washington University

UNITED STATES

View details

Carlos Gamazo

Universidad de Navarra

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Javier Ochoa-Repáraz

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (16)

PICRUSt2 Analysis of Fecal Microbiome Associated With a Murine Model of Multiple Sclerosis

Editorial: Gut microbiota and gastrointestinal disorders, volume II.

A summary of the main themes and findings presented at the ASM Intermountain Branch meeting (2024).

Genetically engineered Lactococcus lactis strain constitutively expresses GABA-producing genes and produces high levels of GABA.

Gut microbiota in multiple sclerosis and animal models

The immunomodulatory roles of the gut microbiome in autoimmune diseases of the central nervous system: Multiple sclerosis as a model

Farnesol brain transcriptomics in CNS inflammatory demyelination

Editorial: Gut microbiota and gastrointestinal disorders

Microbiome Methods in Experimental Autoimmune Encephalomyelitis

Farnesol induces protection against murine CNS inflammatory demyelination and modifies gut microbiome

Exploring the Gut-Brain Axis for the Control of CNS Inflammatory Demyelination: Immunomodulation by Bacteroides fragilis’ Polysaccharide A

Protection Conferred by Drinking Water Administration of a Nanoparticle-Based Vaccine against <i>Salmonella</i> Enteritidis in Hens.

Dysbiosis of the intestinal microbiome as a component of pathophysiology in the inborn errors of metabolism.

A Gut Feeling: The Importance of the Intestinal Microbiota in Psychiatric Disorders.

Editorial: The Role of the Gut Microbiota in Health and Inflammatory Diseases.

The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?

Collaborators (4)

Brett Pickett

Anirban Chakraborty

Andrea Castillo

Carlos Gamazo

Make your next move.